МИКРОСАТЕЛЛИТНАЯ НЕСТАБИЛЬНОСТЬ ПРИ КОЛОРЕКТАЛЬНОМ РАКЕ (обзор литературы)

колоректальный рак, микросателлитная нестабильность, синдром Линча, ген BRAF

1. Семенов Д.А., Ачкасов С.И., Цуканов А.С. и соавт. Синдром Линча. От «семьи G» до ДНК-диагностики. Колопроктология. - 2014. - №3. - с. 57-61.

2. Федянин М.Ю., Трякин А.А., Тюляндин С.А. Роль микросателлитной нестабильности при раке толстой кишки. Онкологическая колопроктология. - 2012. - №3. - с. 19-25.

3. Цуканов А.С., Поспехова Н.И., Шубин В.П. и соавт. Дифференциальный диагноз синдрома Линча от других форм неполипозного колоректального рака среди российских пациентов. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. - 2014. - т. 24. - №2. - с. 78-84.

4. Чернышов С.В. Скрининг колоректального рака. Обзор литературы. Колопроктология. - 2009. -№ 2. - с. 55-59.

5. Янус Г.А., Корнилов А.В., Суспицын Е.Н. и соавт. Молекулярно-генетическая диагностика наследственного неполипозного рака толстой кишки. Сибирский онкологический журнал. - 2012. -№ 2. - с. 29-38.

6. Berg A., Armstrong K., Botkin J. et al. Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet. Med. - 2009 Jan; 11 (1): 35-41.

7. Dietmaier W., Wallinger S., Bocker T. et al. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer. Res. - 1997 Nov; 57 (21): 4749-56.

8. Engel C., Forberg C., Holinski-Feder E. et al. Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancer. Int. J. Cancer. - 2006 Jan 1; 118 (1): 115-22.

9. Evans D.G., Walsh S., Hill J. et al. Strategies for identifying hereditary nonpolyposis colon cancer. Semin. Oncol. - 2007 Oct; 34 (5): 411-7.

10. Giardiello F., Allen J., Axilbund J. et al. Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Dis. Colon. Rectum. - 2014 Aug; 57 (8): 1025-48.

11. Gruber S. New developments in Lynch syndrome (hereditary nonpolyposis colorectal cancer) and mismatch repair gene testing. Gastroenterology. - 2006 Feb; 130 (2): 577-87.

12. lonov Y., Peinado M., Malkhosyan S. et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colorectal carcinogenesis. Nature. - 1993 Jun 10; 363 (6429): 558-61.

13. Kakar S., Burgart L.J., Thibodeau S.N. et al. Frequency of loss of hMLH1 expression in colorectal carcinoma increases with advancing age. Cancer. - 2003 Mar 15; 97 (6): 1421-7.

14. Klingbiel D., Saridaki Z., Roth A. et al. Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial. Ann. Oncol. 2015 Jan; 26 (1): 126-32

15. Le D., Uram J., Wang H. et al. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N. Engl. J. Med. - 2015 Jun 25; 372 (26): 2509-20.

16. Lochhead P., Kuchiba A., Imamura Y. et al. Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication. J. Natl. Cancer Inst. - 2013 Aug 7; 105 (15): 1151-6.

17. Lynch H.T., Shaw M.W., Magnuson C.W. et al. Hereditary factors in cancer: study of two large Midwestern kindreds. Arch. Intern. Med. - 1966 Feb; 117 (2): 206-12.

18. Makrodouli E., Oikonomou E., Koc M. et al. BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study. Mol. Cancer. - 2011 Sep 23; 10: 118.

19. Nakaji Y., Oki E., Nakanishi R. et al. Prognostic value of BRAF V600E mutation and microsatellite instability in Japanese patients with sporadic colorectal cancer.J. Cancer. Res. Clin. Oncol. - 2016 Sep 26. [Epub ahead of print].

20. Peltomaki P., Aaltonen. L.A., Sistonen P. et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science. - 1993 May 7; 260 (5109): 810-2.

21. Potter J., Lindor N. Genetics of colorectal cancer. Springer. - 2008. - р. 185.

22. Rahner N., Steinke V., Schlegelberger B. et al. Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2). Eur. J. Hum. Genet. - 2010 Sep; 18 (9).

23. Roth A.D., Tejpar S., Delorenzi M. et al. Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial. J. Clin. Oncol. - 2010 Jan 20; 28 (3): 466-74.

24. Suraweera N., Duval A., Reperant M. et al. Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. Gastroenterology. - 2002 Dec; 123 (6): 1804-11.

25. Thibodeau S.N., Bren G., Schaid D.J. Microsalellite instability in cancer of the proximal colon. Science. - 1993 May 7; 260 (5109): 816-9.

26. Thibodeau S., French A., Cunningham J. et al. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer. Res. - 1998 Apr 15; 58 (8): 1713-8.

27. Umar A., Boland C., Terdiman J. et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl. Cancer Inst. - 2004 Feb 18; 96 (4): 261-8.

28. Vasen H.F., Mecklin J.P., Khan P.M. et al. International Collaborative Group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis. Colon Rectum. - 1991 May; 34 (5): 424-5.

29. Vasen H., Moslein G., Alonso A. et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J. Med. Genet. - 2007 Jun; 44 (6): 353-62.

30. Vasen H.F., Watsan P., Mecklin J.P. et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. - 1999 Jun; 116 (6): 1453-6.

31. Venderbosch S., Nagtegaal I., Maughan T. et al. Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies. Clin. Cancer Res. - 2014. - 15; 20 (20): 5322-30.

32. Warthin A.S. Heredity with reference to carcinoma as shown by the study of the cases examined in the Pathological Laboratory of the University of Michigan, 1895-1912. Arch. Int. Med. - 1913; 12: 546-55.

33. Wellbrock C., Karasarides M., Marais R. The RAF proteins take centre stage. Nat. Rev. Mol. Cell. Biol. - 2004 Nov; 5 (11): 875-85.

34. Yuan L., Chi Y., Chen W. et al. Immunohistochemistry and microsatellite instability analysis in molecular subtyping of colorectal carcinoma based on mismatch repair competency. Int. J. Clin. Exp. - Med. 2015 Nov 15; 8 (11): 20988-1000.